I suspect they've run out of money again, which means either more support from the lender or administration. Who knows though. I don't like the sounds of either outcome.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025